Today, First National Bank & Trust Co. of Newtown Reduces Position in Johnson & Johnson (JNJ)

Today, First National Bank & Trust Co. of Newtown Reduces Position in Johnson & Johnson (JNJ)

First National Bank & Trust Co. of Newtown lowered its position in shares of Johnson & Johnson (NYSE:JNJ) by 1.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 56,922 shares of the company’s stock after selling 590 shares during the period. Johnson & Johnson comprises approximately 2.1% of First National Bank & Trust Co. of Newtown’s portfolio, making the stock its 9th largest position. First National Bank & Trust Co. of Newtown’s holdings in Johnson & Johnson were worth $6,724,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Cullen Frost Bankers Inc. increased its position in shares of Johnson & Johnson by 0.3% in the third quarter. Cullen Frost Bankers Inc. now owns 209,692 shares of the company’s stock worth $24,771,000 after buying an additional 612 shares during the period. Round Table Services LLC increased its position in shares of Johnson & Johnson by 2.6% in the third quarter. Round Table Services LLC now owns 4,442 shares of the company’s stock worth $525,000 after buying an additional 111 shares during the period. Asset Advisors Corp increased its position in shares of Johnson & Johnson by 0.5% in the third quarter. Asset Advisors Corp now owns 169,151 shares of the company’s stock worth $19,982,000 after buying an additional 898 shares during the period. Delta Asset Management LLC TN increased its position in shares of Johnson & Johnson by 1.8% in the third quarter. Delta Asset Management LLC TN now owns 24,958 shares of the company’s stock worth $2,948,000 after buying an additional 437 shares during the period. Finally, Beese Fulmer Investment Management Inc. increased its position in shares of Johnson & Johnson by 3.2% in the third quarter. Beese Fulmer Investment Management Inc. now owns 96,757 shares of the company’s stock worth $11,431,000 after buying an additional 3,034 shares during the period. Institutional investors own 65.19% of the company’s stock.

Shares of Johnson & Johnson (NYSE:JNJ) traded up 0.94% during trading on Friday, hitting $114.13. 3,433,340 shares of the stock traded hands. The firm has a market cap of $310.49 billion, a PE ratio of 20.03 and a beta of 0.75. Johnson & Johnson has a 52-week low of $94.28 and a 52-week high of $126.07. The company’s 50 day moving average is $116.14 and its 200 day moving average is $118.35.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, October 18th. The company reported $1.68 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.66 by $0.02. Johnson & Johnson had a net margin of 22.03% and a return on equity of 25.30%. The firm earned $17.80 billion during the quarter, compared to analysts’ expectations of $17.71 billion. During the same quarter last year, the business earned $1.49 earnings per share. The business’s revenue for the quarter was up 4.2% compared to the same quarter last year. On average, equities research analysts predict that Johnson & Johnson will post $6.72 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 6th. Investors of record on Tuesday, November 22nd will be paid a $0.80 dividend. This is a boost from Johnson & Johnson’s previous quarterly dividend of $0.29. The ex-dividend date is Friday, November 18th. This represents a $3.20 annualized dividend and a dividend yield of 2.80%. Johnson & Johnson’s dividend payout ratio (DPR) is 56.64%.

A number of analysts have recently commented on the stock. Credit Suisse Group AG reissued a “neutral” rating and set a $123.00 target price on shares of Johnson & Johnson in a research note on Monday, September 19th. Vetr cut shares of Johnson & Johnson from a “buy” rating to a “hold” rating and set a $119.60 target price for the company. in a research note on Tuesday, November 1st. Zacks Investment Research raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $139.00 target price for the company in a research note on Friday, August 5th. Jefferies Group boosted their target price on shares of Johnson & Johnson from $113.00 to $119.00 and gave the stock a “hold” rating in a research note on Thursday, August 4th. Finally, Deutsche Bank AG reissued a “buy” rating and set a $142.00 target price on shares of Johnson & Johnson in a research note on Friday, August 19th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $120.79.

In related news, Director Charles Prince acquired 875 shares of Johnson & Johnson stock in a transaction that occurred on Friday, October 21st. The stock was purchased at an average price of $114.11 per share, for a total transaction of $99,846.25. Following the completion of the purchase, the director now directly owns 26,520 shares of the company’s stock, valued at $3,026,197.20. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 0.11% of the stock is currently owned by corporate insiders.

About Johnson & Johnson

Related posts

Leave a Comment